Profile
FEMY ISRG BDXA BDX ALC RMD
Company Name Femasys Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $20.46M $192.04B $55.91B $53.26B $37.61B $37.14B
Employees 0.07K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Kathy Lee-Sepsick Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
FEMY ISRG BDXA BDX ALC RMD
Quant Rating Score 1 3 5 3 3 4
Quant Rating Strong Sell Neutral Strong Buy Neutral Neutral Buy
Trading
FEMY ISRG BDXA BDX ALC RMD
Last Close $0.6294 $537.59 $59.24 $181.52 $73.6 $253.62
High 52 $1.77 $610.45 $59.24 $249.08 $98.3 $293.73
Low 52 $0.34 $429.59 $59.24 $165.15 $72.05 $204.58
Price vs. 52 Week High -64.44 % -11.94 % 0 % -27.12 % -25.13 % -13.66 %
Price vs. 52 Week Low 85.12 % 25.14 % 0 % 9.91 % 2.15 % 23.97 %
Total Return
FEMY ISRG BDXA BDX ALC RMD
1 Month Return 78.6 % 20.2 % 0 % -3.02 % -1.21 % -7.35 %
3 Month Return -24.17 % 7.41 % 0 % -0.01 % -17.49 % -8.58 %
6 Month Return -45.74 % 4.05 % 0 % -12.35 % -24.69 % 7.09 %
9 Month Return -47.11 % -7.34 % 0 % -26.95 % -20.28 % -1.56 %
YTD Return -42.78 % 2.99 % 0 % -19.99 % -13.3 % 10.9 %
1 Year Return -53.72 % 4.64 % 0 % -23.28 % -21.09 % 4.36 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
FEMY ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) - - 2.26 % 2.24 % 0.44 % 0.86 %
Dividend Paid and Capex Coverage Ration (TTM) -26.52 % 4.3 % 1.73 % 1.73 % 3.26 % 4.34 %
Dividend Per Share (TTM) - - 4.16 % 4.16 % 0.33 % 2.19 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 15.71 % 22.19 %
Growth
FEMY ISRG BDXA BDX ALC RMD
Asset Growth -55.16 % 8.54 %
Gross Profit Growth 56.7 % 11.69 %
Revenue Growth 51.97 % 4.16 %
Revenue 3 Year -26.79 % 5.3 %
Revenue 5 Year -7.38 % 8.72 %
Revenue 10 Year -7.38 % 59.37 %
EBIT Growth -22.21 % 19.82 %
Net Income Growth -32.07 % 14.89 %
Net Income 3 Yeari Growth Per Share -32.33 % -18.63 %
Net Income 5 Yeari Growth Per Share 11.83 % 28.82 %
Net Income 10 Yeari Growth Per Share 11.83 % -4.02 %
Operating Income Growth -22.59 % 13.55 %
Operating Cash Flow Growth (CFG) -72.37 % 27.07 %
Operating 3 Year CFG -29.97 % -18.4 %
Operating 5 Year CFG 6.69 % 6.25 %
Operating 10 Year CFG 6.69 % 45.28 %
EPS Growth 9.68 % 18.31 %
EPS Diluted Growth 9.68 % 18.62 %
Book Value Per Share -91.33 % -0.85 %
Share Holder 3 Year Equity Growth Per Share -95.36 % 9.16 %
Share Holder 5 Year Equity Growth Per Share 102.68 % 14.4 %
Share Holder 10 Year Equity Growth Per Share 102.68 % 241.78 %
Dividend Per Share Growth - -2.44 %
Dividend 3 Year Growth Per Share - 4.79 %
Dividend 5 Year Growth Per Share - 4.14 %
Dividend 10 Year Growth Per Share - 74.3 %
Debt Growth 11.06 % 31.74 %
Free Cash Flow Growth -76.86 % 45.25 %
Updated On 31 Dec 2024 30 Sep 2024
Profitability
FEMY ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM 53.71 % 66.41 % 45.08 % 45.08 % 55.13 % 59.36 %
Return on Assets TTM -864.98 % 14.19 % 2.93 % 2.93 % 3.42 % 17.14 %
Return on Equity TTM -713.69 % 16.08 % 6.31 % 6.31 % 4.93 % 25.51 %
Return on Capital Employed TTM 224.43 % 16.05 % 5.78 % 5.78 % 4.98 % 23.55 %
Net Income Per EBT TTM 100.03 % 86.77 % 83.91 % 83.91 % 85.57 % 83.5 %
EBT Per Ebit TTM 109.68 % 112.41 % 70.86 % 70.86 % 86.96 % 99.54 %
EBIT Per Revenue TTM -1015 % 29.3 % 12.63 % 12.63 % 14.38 % 32.75 %
Cash Flow To Debt Ratio TTM -250.46 % - 16.82 % 16.82 % 39.27 % 198.52 %
Receivables Turnover TTM 7.41 7.63 7.27 7.27 4.98 5.48
Payables Turnover TTM 0.27 11.09 1.85 1.85 5.03 7.52
Inventory Turnover TTM 0.17 1.81 2.97 2.97 1.88 2.25
Fixed Asset Turnover TTM 60.01 % 186.61 % 313.67 % 313.67 % 197.54 % 716.47 %
Asset Turnover TTM 77.67 % 49.67 % 38.95 % 38.95 % 31.94 % 62.96 %
Operating Cash Flow Per Share TTM -0.68 8.3 11.3 11.3 4.16 11.96
Free Cash Flow Per Share TTM -0.71 6.37 8.85 8.85 3.23 11.32
Cash Per Share TTM 11.14 % 1376.56 % 262.85 % 262.85 % 284.33 % 825.72 %
Operating Cash Flow Sales Ratio TTM -1042.24 % 30.8 % 15.22 % 15.22 % 20.57 % 34.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.77 % 76.72 % 78.37 % 78.37 % 77.51 % 94.7 %
Cash Flow Coverage Ratios TTM -250.46 % - 16.82 % 16.82 % 39.27 % 198.52 %
Price To Free Cash Flows Ratio TTM -1 84.55 20.71 20.89 23.53 22.39
Price To Operating Cash Flows Ratio TTM -0.92 64.75 16.3 16.45 18.27 21.21
Price Cash Flow Ratio TTM -0.92 64.75 16.3 16.45 18.27 21.21
Income Statement (TTM)
FEMY ISRG BDXA BDX ALC RMD
Revenue $0B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $0B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 66.55% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $-0.02B $2.81B $4.82B $4.82B $2.68B $1.91B
Net Income $-0.02B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted -0.84 6.42 5.86 5.86 2.05 9.51
Balance Sheet (MRQ)
FEMY ISRG BDXA BDX ALC RMD
Long Term Debt $0B $0.11B $18.61B $18.61B $4.97B $0.81B
Total Liabilities $0.01B $2.31B $31.4B $31.4B $8.79B $2.21B
Total Equity $0B $16.53B $25.89B $25.89B $21.55B $5.97B
Total Investments $0B $7.05B $0.45B $0.45B $0.91B $0.09B
Total Debt $0.01B $0.15B $20.92B $20.92B $5.14B $0.88B
Total Assets $0.01B $18.84B $57.29B $57.29B $30.35B $8.17B
Cash Flow Statement (TTM)
FEMY ISRG BDXA BDX ALC RMD
Net Income $-0.02B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $-0B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $-0.02B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 74.25
ANGO AngioDynamics, Inc. 12.135
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 124.26
ATRC AtriCure, Inc. 34.07
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.05
AZTA Azenta, Inc. 29.91
BAX Baxter International Inc. 19.175
BDX Becton, Dickinson and Company 179.285
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.155
BLFS BioLife Solutions, Inc. 26.91
COO The Cooper Companies, Inc. 70.1
DXR Daxor Corporation 13.36
EKSO Ekso Bionics Holdings, Inc. 5.09
ETFs With Exposure to FEMY
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00001 334.17
VXF Vanguard Extended Market Index Fund 0.00009 209.455
IWC iShares Micro-Cap ETF 0.00331 155.19
DFAS Dimensional U.S. Small Cap ETF 0.00006446 67.68
VTSAX Vanguard Total Stock Market Index Fund 0.00001 164.31
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00009 160.9
VITSX Vanguard Total Stock Market Index Fund 0.00001 164.34
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00009 160.91
VTS.AX Vanguard US Total Market Shares Index ETF 0.00001 512.34
VEMPX Vanguard Extended Market Index InstlPlus 0.00009 397.07
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00001 308.28
Unlock